Healthy Extracts Reports 45% Revenue Jump to Record $4.5M With Gummy USA Merger

GELSGELS

Healthy Extracts reported preliminary 2025 net revenue of $4.5 million, a 45% increase driven by its merger with Gummy USA, 25% organic growth and 47% rise in direct-to-consumer subscriptions. Management expects the Gummy USA facility to reach $20 million annual capacity in 2026, supporting projections for over 344% revenue growth.

1. Preliminary 2025 Financial Results

Healthy Extracts delivered preliminary unaudited net revenue of $4.5 million for 2025, representing a 45% increase over the prior year. This record performance marks the fifth consecutive quarter of revenue growth and establishes a new annual high.

2. Operational Drivers and Subscription Growth

The 45% net revenue increase was driven by the merger with Gummy USA, which contributed to organic growth of 25%. Direct-to-consumer subscriptions rose 47% while Amazon Subscribe & Save customers increased 36%, bolstering recurring revenue and customer lifetime value.

3. 2026 Outlook and Capacity Projections

Management projects the Gummy USA manufacturing facility to reach its $20 million annual production capacity during 2026, supporting potential revenue growth exceeding 344%. New product launches across fiber-based and precision-dosed gummy technologies are expected to further enhance profitability.

4. Strategic Evolution and Nasdaq Uplist

The company is advancing into Nutra Pharma and Health & Beauty segments with proprietary SureDose™ delivery systems and clinical readiness for FDA Pharma approval. Plans for a Nasdaq uplisting aim to improve liquidity, attract institutional investors and support further M&A.

Sources

F